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pen access Abstract Background: Spinal fusion surgeries are accompanied by signiﬁcant blood loss. Acute
normovolemic hemodilution is one of the autologous blood transfusion techniques that is proved
to improve tissue perfusion through decreasing blood viscosity. However, its effect on hemodynam-
ics, hematologic state, and coagulation proﬁle is controversial.
Aim of the work: To detect safety of ANH as an alternative to allogenic blood transfusion in major
surgeries.
Patients and methods: Forty adult patients undergoing spinal fusion surgery were randomly
assigned into two groups: hemodilution group (group H: n= 20) and control group (group C:
n= 20). Samples were collected ﬁve times. T1: just after the induction of anesthesia and before
hemodilution starts. T2: just after the end of hemodilution or 40 min after the induction of anesthe-
sia in the control group. T3: at the start of surgical closure.T4: before the reversal from residual
neuromuscular effect. T5: 3 h postoperative. Samples included: Arterial blood gases (ABGs), Hb
level, Ht%, serum Na+ and K+ levels, platelet count (Plt), bleeding time (BT), activated partial
thromboplastin time (aPTT), and international neutralizing ratio (INR).
Results: Heart rate, arterial blood pressure and CVP showed no signiﬁcant differences during
intra- and postoperative times between the two groups. Reduction in Hb and Ht % occurred in
both groups compared to basal and was more signiﬁcantly reduced in group H compared to group
C at T2. Platelets were reduced in both groups compared to basal and signiﬁcantly reduced in group
H at T2 compared to group C. BT, aPTT, and INR were not affected all through the study time in
both groups. Serum Na+, Serum K+, and ABGs showed insigniﬁcant differences all through the
study time.329364.
(S.H. Waly).
Anesthesiologists. Production
an Society of Anesthesiologists.
lsevier
under CC BY-NC-ND license.
250 M.I. El-Dessouky et al.Conclusions: Acute normovolemic hemodilution can be considered as a safe and effective alterna-
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Adequate volume replacement duringmajor surgeries is manda-
tory in order to avoid organ dysfunction and death [1]. The
hazards related to homologous blood transfusion are well
known, andmight include: hypothermia, coagulation problems,
hyperkalemia, hypocalcemia, allergic reactions, acute lung
injury, hemolytic and non-hemolytic reactions, and transmitted
infections [2].
Although multiple measures are performed to increase the
safety of donated blood and/or products, autologous blood
remains the safest source for blood transfusion [3]. Autologous
blood donation may be performed by either: pre-deposit autol-
ogous transfusion (The patient donates blood 3–5 weeks before
surgery to be used intraoperatively), intraoperative acute
normovolemic hemodilution, or intraoperative red blood cell
salvage [4].
Acute normovolemic (isovolemic) hemodilution (ANH) is a
blood conservation technique which involves intraoperative
removal and storage (at room temperature) of blood from a
patient, just before or shortly after the induction of anesthesia,
with simultaneous adding of a replacement volume of crystal-
loid and/or colloid [5]. This blood is transfused again to the same
patient when intra-operative blood loss is controlled, or when
necessary [6].
ANH is indicated when blood loss is expected to be more
than 1 l or expected to exceed 20%of the patients’ blood volume
[4].
Spinal surgeries might range from cervical to lumbosacral
levels. Spinal fusion might involve distractive forces and/or
ﬁxation by special instruments ofmultiple spinal levels. Applica-
tion of these devices may be associated with clinically signiﬁcant
blood loss [7].
The aim of the present study is to reveal the efﬁcacy and
safety of acute normovolemic hemodilution compared to
homologous blood transfusion in spine surgery patients.2. Patients and methods
After local ethics committee approval and an informed written
patient consent, 40 adult ASA I-II patients of both sexes (aged
between 25 and 40 years), undergoing spinal fusion surgerywere
included in the current study. Exclusion criteria included:
patients with cardiac disease, uncontrolled hypertension,
respiratory impairment (PaO2 < 60 mm Hg on room air),
impaired renal (creatinine > 1.5 mg/dl) or hepatic function
(serum bilirubin > 1.5 mg/dl or doubled AST), hemoglobin
(Hb) level < 12 gm/dl, and coagulopathies (platelet count <
100 · 103/cc, INR > 1.2).
Patients were randomly assigned into two groups: hemodi-
lution group (group H: n= 20) and control group (group C:
n= 20). Randomization was done by closed envelopes.2.1. Anesthetic technique
For both groups general anesthesia was performed. Patients
were premedicated with 0.1 mg/kg midazolam and 0.5 mg atro-
pine intramuscularly 1 h before surgery.Anesthesiawas induced
with fentanyl 1 lg/kg and thiopental sodium 6 mg/kg. Atracuri-
um 0.5 mg/kg i.v. was given and 100% oxygen via a face mask
for 2–3 min was applied. Appropriate size cuffed endotracheal
tube was inserted. Anesthesia was maintained with isoﬂurane
and muscle relaxation was maintained using incremental doses
of atracurium (0.05 mg/kg) as required. Repeated doses of fen-
tanyl were given intraoperatively as needed. Patients were venti-
lated tomaintain an end-tidal Pco2 of 35–40 mm Hg throughout
the whole procedure. Depth of anesthesia was monitored by
clinical signs and hemodynamic responses to surgical stimuli.
All patients were put in prone position. Controlled hypotension
was done by reducing systolic arterial pressure not more than
30% less than the initial values or maintaining mean arterial
pressure (MAP) at 60 mm Hg. This was achieved by gradual
increasing of the maintenance isoﬂurane (0.5% every 5 min) un-
til targetedMAPwas achieved. This was accompanied by hyper-
ventilation inwhich the rate adjusted to achieve targeted PaCO2
of 30–35 mm Hg (provided that the minute ventilation was held
constant).
Arterial cannula (20 G) was inserted in non dominant hand
of the patient after performing Allen’s test. This cannulation
aimed for arterial blood sampling to detect oxygenation and
acid–base status and for continuous blood pressure monitoring.
Central venous catheter was applied into internal jugular
vein under complete aseptic conditions.
For all patients intraoperative monitoring included pulse
oximetry, ECG, End tidal CO2, CVP, and arterial blood pres-
sure monitoring.
All patients were reversed with i.v. Neostigmine 0.05 mg/kg
and Atropine 0.02 mg/kg then extubated.
2.2. Postoperative follow up
Patients were carefully monitored for 3 h postoperatively. It
was planned to transfuse autologous blood if volume expan-
sion was needed.
2.3. Estimated allowable blood loss (EBL)
It was calculated from the following formula [8]:
EBL ¼ EBV ðinitial Hb targeted HbÞ=mean Hb
where EBV = estimated blood volume; Hb = hemoglobin;
mean Hb = arithmetic mean of initial Hb, and the targeted
Hb.
EBV is calculated for all patients as 70 ml · body weight.
The targeted Hb level in the current study was 9 gm/dl and
the lowest hematocrit (Ht) allowed was 25%.
Table 1 Patients’ demographic data.
Group C (n= 20) Group H (n= 20)
Age (yr) 39.2 ± 8.3 38.9 ± 9.2
Weight (kg) 82.1 ± 7.4 80.6 ± 8.9
Male/female 16/4 17/3
Length of surgery (min) 148.3 ± 39.2 159.9 ± 43.8
EBV (ml) 5676 ± 459 5873 ± 372
EABL (ml) 1500 ± 244 1633 ± 183
BL (ml) 1200 ± 400 1300 ± 350
Data were expressed as mean (±SD) or ratio.
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The technique applied in the current study followed the guide-
lines for autologous transfusion by Napier et al. [9] [British
Committee for Standards in Haematology Blood Transfusion
Task Force].
After applying all monitoring devices and before putting
the patient in prone position, hemodilution was started just
after the induction of anesthesia. Two units of whole blood
were withdrawn and collected via ante-cubital vein into stan-
dard blood collecting bags [Citrate – phosphate – dextrose –
Adenine anticoagulant bag (CPD – A)]. The blood was sealed,
and labeled with patient identiﬁcation and time of collection.
‘‘Untested blood for autologous use only’’ was written on all
blood bags’ labels. Harvested blood was stored at room tem-
perature in the operating room.
Concomitantly, Voluven (6% hydroxyethyl starch 130/
0.4 in 0.9% sodium chloride injection) [Fresenius Kabi, Ger-
many] was infused into the central line in a rate equal to the
blood collection rate (1:1 volume).
At the proper time all harvested blood was re-infused to the
patient in the reverse order of collection (2nd bag infused ﬁrst).
During the time of hemodilution, continuous invasive
blood pressure and continuous ECG monitoring were per-
formed. CVP was measured and recorded every 10 min.
2.5. Time of blood transfusion
In the hemodiluton group (group H): all patients were re-in-
fused with their blood after surgical hemostasis was performed
or when maximum calculated allowable blood loss was
reached. It was planned to use allogenic blood in this group
if blood loss exceeded 500 ml more than harvested blood.
In the control group (group C): allogenic blood transfused
when maximum calculated allowable blood loss was reached
or when the Hb 6 9 gm/dl and/or Ht 6 25 %.
2.6. Sampling
Samples were collected at ﬁve times.
T1: just after the induction of anesthesia and before hemod-
ilution starts.
T2: just after the end of hemodilution or 40 minutes after
the induction of anesthesia in the control group.
T3: at the start of surgical closure (surgical hemostasis was
achieved).
T4: before the reversal from residual neuromuscular effect
(end of surgery).
T5: 3 hours postoperative.
Samples included: Arterial blood gases (ABGs), Hb level,
Ht%, serum Na+ and K+ levels. Hemostasis was also investi-
gated through: platelet count (Plt), bleeding time (BT), acti-
vated partial thromboplastin time (aPTT), and international
neutralizing ratio (INR).
2.7. Statistical analysis
Data entry and statistical analysis were performed using the
SPSS software (SPSS, Chicago, IL,USA). Qualitative data werepresented as a number or ratio, while quantitative data were
presented as mean ± standard deviation (SD). The chi-square
test (v2) was used to test associations between variables of
qualitative data. Two-way repeated measure analysis of
Variance was used for continuous variables as HR and MAP
and the differences were then calculated byNewman–Keuls test.
Paired and non-paired t-tests, MannWhitney U, andWilcoxon
tests were applied. Differences were considered signiﬁcant at
(P< 0.05).
3. Results
Patients’ data including: age, weight, gender, duration of
surgery, estimated blood volume, estimated allowable blood
loss, and actual blood loss; showed insigniﬁcant differences
between the two groups (Table 1).
Regarding cardiovascular data, heart rate and CVP showed
no signiﬁcant differences during intra- and postoperative times
in both groups. Blood pressure was signiﬁcantly lower than
basal levels just before skin incision and for one hour later
in both groups which may be attributed to a controlled
hypotension technique employed within the maneuver at this
time of surgery (Table 2).
There were signiﬁcant reductions in both Hb and Ht % in
both groups during intra-operative time and 3 h postopera-
tively compared to the basal levels. During the time of hemod-
ilution (T2), the reduction in Hb and Ht % was more
signiﬁcant in hemodilution group compared to the control
group (Table 3).
Platelet count was signiﬁcantly reduced compared to the
basal level in both groups during intra-operative and 3 h after
the end of surgery. Signiﬁcant reduction was encountered in
the hemodilution group at T2 (time of hemodilution) com-
pared to the control group. Thrombocytopenia was deﬁned
as PLT < 100 · 103/lL. Bleeding time, activated partial
thromboplastin time (aPTT), and INR were not affected all
through the study time in both groups (Table 4).
Serum Na+ and K+ showed insigniﬁcant differences all
through the study time (Table 5).
Regarding patients’ oxygenation and ventilation as shown
by ABGs, collected data revealed insigniﬁcant variations be-
tween the two groups (Table 6).
None of the patients in groupHneeded homologous transfu-
sion neither during intra-operative, nor postoperative periods.
4. Discussion
Blood loss during spinal fusion surgery is expected to be
10–30 ml/kg because of the rich vasculature of the area besides
Table 4 Intra- and postoperative coagulation parameters.
T1 (basal) T2 T3 T4 T5
PLT (· 103 l/L) Group C 311 ± 37 230 ± 42* 201 ± 22* 222 ± 29* 211 ± 33*
Group H 315 ± 34 183 ± 33*, 191 ± 34* 212 ± 34* 205 ± 39*
BT (min) Group C 1.8 ± 0.4 1.7 ± 0.6 1.7 ± 0.6 1.6 ± 0.7 1.7 ± 0.7
Group H 1.9 ± 0.2 1.7 ± 0.5 1.6 ± 0.6 1.7 ± 0.5 1.7 ± 0.8
aPTT (s) Group C 38 ± 3 37 ± 4 36 ± 6 37 ± 3 36 ± 5
Group H 38 ± 2 36 ± 3 36 ± 5 37 ± 4 37 ± 5
INR Group C 1.1 ± 0.05 1.1 ± 0.06 1.1 ± 0.01 1.1 ± 0.03 1.1 ± 0.05
Group H 1.1 ± 0.04 1.1 ± 0.04 1.1 ± 0.03 1.1 ± 0.05 1.1 ± 0.06
PLT = platelet count, BT = bleeding time (normal: 1–3 min), aPTT = activated partial thromboplastin time (normal: 25–40 s), INR =
international neutralizing ratio (normal: 1).
Data were expressed as mean ± SD; signiﬁcant, P> 0.05.
* Signiﬁcantly lower as compared to basal data within the same group.
 Signiﬁcantly lower as compared to data obtained in the same time within the other group.
Table 3 Intra- and postoperative hemoglobin and hematocrit.
T1 (basal) T2 T3 T4 T5
Hb (gm/dl) Group C 13.3 ± 0.7 12.2 ± 1.3* 12.0 ± 1.5* 12.2 ± 1.1* 12.4 ± 0.9*
Group H 13.1 ± 1.1 11.9 ± 0.3*, 12.0 ± 0.2* 12.2 ± .3* 12.2 ± 1.6*
Ht (%) Group C 38.6 ± 1.6 36.6 ± 2.4* 35.5 ± 1.1* 36.3 ± 1.8* 36.2 ± 1.3*
Group H 39.2 ± 1.1 33.3 ± 0.2*, 34.9 ± 1.4* 35.9 ± 1.9* 36.7 ± 1.2*
Hb = hemoglobin, and Ht = hematocrit.
Data were expressed as mean ± SD; signiﬁcant, P> 0.05.
* Signiﬁcantly lower as compared to basal data within the same group.
 Signiﬁcantly lower as compared to the data obtained in the same time within the other group.
Table 5 Intra- and postoperative serum Na+ and K+.
T1 (basal) T2 T3 T4 T5
Na+ (meq/L) Group C 141.1 ± 3.3 142.0 ± 2.8 141.1 ± 4.1 141.1 ± 3.0 142.3 ± 5.9
Group H 141.4 ± 3.3 140.9 ± 3.2 142.0 ± 5.6 141.4 ± 2.9 140.9 ± 2.3
K+ (meq/L) Group C 4.0 ± 0.4 3.8 ± 0.3 3.8 ± 0.3 3.9 ± 0.1 3.8 ± 0.3
Group H 4.0 ± 0.4 3.9 ± 0.2 3.9 ± 0.4 3.9 ± 0.2 3.9 ± 0.2
Data are expressed as mean (±SD).
Table 2 Intra- and postoperative cardiovascular data.
24 hours before
surgery (basal)
Just after induction
of anesthesia
Just before skin
incision
60 min after
skin incision
At the start of
surgical closure
3 hours
post-operative
HR Group C 84.0 ± 8.7 81.0 ± 12.6 81.6 ± 11.4 81.4 ± 10.7 82.9 ± 10.7 81.5 ± 10.9
Group H 83.8 ± 9.3 82.8 ± 9.9 81.8 ± 10.1 83.8 ± 9.9 81.9 ± 11.1 82.1 ± 11.2
MAP Group C 88 ± 13 86 ± 15 68 ± 8* 67 ± 9* 81 ± 11 88 ± 15
Group H 86 ± 16 84 ± 12 68 ± 10* 65 ± 11* 82 ± 8 86 ± 14
CVP Group C 7.01 ± 1.2 6.8 ± 1.3 6.5 ± 1.7 6.7 ± 1.4 6.69 ± 1.5 6.8 ± 1.2
Group H 6.95 ± 1.1 6.7 ± 1.2 6.5 ± 1.8 6.6 ± 1.6 6.68 ± 1.4 6.9 ± 1.6
HR = heart rate (beat/min), MAP = mean arterial blood pressure (mm Hg), CVP = central venous pressure (cm water).
Data were expressed as mean ± SD; signiﬁcant, P> 0.05.
* Signiﬁcantly lower as compared to basal data within the same group
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fusion [10].
Acute normovolemic hemodilution in this clinical study
demonstrated stable hemodynamics, with non-signiﬁcantalteration in hematologic state, hemostatic condition, serum
electrolytes, or arterial blood gases when compared to allogen-
ic blood transfusion. Thereby, homologous blood transfusion
can be avoided by applying ANH technique.
Table 6 Intraoperative arterial blood gas analysis (ABG) on 100% O2.
T1 (basal) T2 T3 T4
SaO2 (%) Group C 99.6 ± 0.3 99.5 ± 0.3 99.5 ± 0.2 99.5 ± 0.1
Group H 99.5 ± 0.4 99.4 ± 0.2 99.4 ± 0.1 99.5 ± 0.4
PaO2 Group C 446.4 ± 16.1 440.3 ± 21.9 439.4 ± 39.8 433.8 ± 23.9
Group H 442.0 ± 36.2 434.4 ± 34.6 436.9 ± 34.4 444.5 ± 63.5
PaCO2 Group C 37.1 ± 2.4 33.1 ± 2.8 35.6 ± 2.1 36.0 ± 2.9
Group H 37.2 ± 2.3 33.7 ± 2.5 35.2 ± 2.7 36.6 ± 2.7
Arterial (pH) Group C 7.42 ± 0.04 7.39 ± 0.04 7.37 ± 0.03 7.43 ± 0.06
Group H 7.43 ± 0.04 7.44 ± 0.05 7.42 ± 0.05 7.42 ± 0.05
HCO3 Group C 26.4 ± 2.6 27.6 ± 2.2 27.2 ± 2.2 27.8 ± 2.3
Group H 26.3 ± 2.3 25.4 ± 2.3 25.2 ± 1.3 27.9 ± 2.2
BE Group C 3.0 ± 2.7 4.1 ± 2.4 3.3 ± 2.7 3.7 ± 2.8
Group H 2.8 ± 1.4 1.6 ± 1.9 0.5 ± 1.5 4.0 ± 2.4
SaO2 = O2 saturation, PaO2 = arterial partial pressure of oxygen, PaCO2 = arterial partial pressure of carbon dioxide, HCO3 = bicarbonate,
and BE = base excess.
Data are expressed as mean (±SD).
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with the results obtained by a study performed by Hur et al.
[11] who found that the technique of ANH reduced the de-
mand for allogenic blood transfusion in spinal surgery.
In the present study, the heart rate stability in both groups
reﬂects proper anesthetic technique and intraoperative ﬂuid
management (rate and volume). This was in contrast to the re-
sults obtained by Weiskopf et al. [12] who demonstrated that
the technique of ANH was accompanied by tachycardia. The
hemodynamic stability in the present was in agreement with
the results obtained by other studies performed by Ickx et al.
[13] and Bak et al. [14].
In the current study, both groups have shown reduction in
Hb and Ht %. In the hemodilution group, this could be attrib-
uted to the technique itself; while in the control group, this
could be explained by surgical blood loss with concomitant
administration of crystalloids. Such reduction in hematologic
parameters was not accompanied by disturbances in acid base
balance and did not fall below the values shown to be accepted
for adequate oxygen delivery to various organs especially the
brain (Hb of 11.3 mg/dl and Ht of 30%) [15].
A study conducted by Deem et al. [16] reviewed other studies
evaluating the relationship between normovolemic hemodilu-
tion and arterial O2 and CO2 tensions in rabbits and concluded
that such parameters where not affected by ANH. This was in
agreement with the results obtained by the present study.More-
over, Szegedi et al. [17] demonstrated thatANH is not a safe pro-
cedure regarding the issue of ventilation if patients were not
properly selected according to their pulmonary functions and
those with poor lung performance were excluded.
Two factors have been accused within the subject of coagula-
tion disorders that might occur with ANH: Extreme hemodilu-
tion (Ht 6 20%) with concomitant decrease in coagulation
factors [18], and the type of the replacement ﬂuid used [19]. Since
hemostatic disorders were not encountered in the current study;
therefore, these results supported the guidelines of ANH which
state that Ht % should be kept between 25% and 30% [9].
McLaughlin et al. [18] recommended fresh frozen plasma as a
replacement ﬂuid if extreme hemodilution is to be performed.
Many studies that found HES to cause impaired hemostasis
were conducted upon ﬁrst-generation HMW HES [20–22].
LMWHES (HES 130/0.4) has a better effect on the hemostatic
condition [19] that may be attributed to its different physico-chemical properties than hetastarch [23] which was found to
affect both the coagulation factors and the platelet aggregation
[22].
5. Conclusion
Acute normovolemic hemodilution is a safe, effective alterna-
tive for allogenic blood transfusion in spinal fusion surgery
with consequent avoidance of the expected hazards of homol-
ogous blood.
References
[1] Mythen MG, Webb AR. Intra-operative gut mucosal
hypoperfusion is associated with increased post-operative
complications and costs. Intensive Care Med 1994;20:99–104.
[2] Rosenblatt MA. Strategies for minimizing the use of allogeneic
blood during orthopedic surgery. Mt Sinai J Med 2002;69(1-2):
83–7.
[3] Murray D. Acute normovolemic hemodilution. Eur Spine J
2004;1:S72–5.
[4] Vanderlinde ES, Heal JM, Blumberg N. Clinical review:
autologous transfusion. Br Med J 2002;324:772–5.
[5] Lee D, Chapman J, Contreras II M, et al. Perioperative
haemodilution and cell salvage. British Committee for
Standards in Haematology Blood Transfusion Task Force. Br
J Anaesth 1997;78:768–71.
[6] Duguid JKM. Autologous blood transfusion: review. Clin Lab
Haematol 1999;21:371–6.
[7] Raw DA, Beattie JK, Hunter JM. Anaesthesia for spinal surgery
in adults. Br J Anaesth 2003;91(6):886–904.
[8] Gross JB. Estimating allowable blood loss: corrected for
dilution. Anesthesiology 1983;58:277–80.
[9] Napier JA, Bruce M, Chapman J, Duguid JK, Kelsey PR,
Knowles SM, Murphy MF, Williamson LM, Wood JK, Lee D,
Contreras M, Cross N, Desmond MJ, Gillon J, Lardy A,
Williams FG. Guidelines for autologous transfusion. II.
Perioperative haemodilution and cell salvage. British
Committee for Standards in Haematology Blood Transfusion
Task Force. Autologous transfusion working party. Br J
Anaesth 1997;78(6):768–71.
[10] Zheng Jr F, Cammisa FP, Sandhu HS, Girardi FP, Khan SN.
Factors predicting hospital stay, operative time, blood loss, and
transfusion in patients undergoing revision posterior lumbar
spine decompression, fusion, and segmental instrumentation.
Spine 2002;27:818–24.
254 M.I. El-Dessouky et al.[11] Hur SR, Huizenga BA, Major M. Acute normovolemic
hemodilution combined with hypotensive anesthesia and other
techniques to avoid homologous transfusion in spinal fusion
surgery. Spine 1992;17:867–73.
[12] Weiskopf RB, Feitner J, Hopf H, Viele MK, Watson JJ,
Lieberman J, Kelley S, Toy P. Heart rate increases linearly in
response to acute isovolemic anemia.Transfusion2003;43:235–40.
[13] Ickx BE, Rigolet M, Van der Linden PJ. Cardiovascular and
metabolic responses to acute normovolemic anemia: effects of
anesthesia. Anesthesiology 2000;93:1011–6.
[14] Bak Z, Abilgard L, Lisander B, Sjo¨berg J. Transesophageal
echocardiographic hemodynamic monitoring during
preoperative acute normovolemic hemodilution.
Anesthesiology 2000;92:1250–6.
[15] Han SH, Ham BM, Bahk JK, Bahk JH, Ro YJ, Do SH, Park
YS. The effect of acute normovolemic hemodilution on cerebral
oxygenation. Int J Clin Pract 2004;5810:903–6.
[16] Deem S, Alberts MK, Bishop MJ, Bidani A, Swenson ER. CO2
transport in normovolemic anemia: complete compensation and
stability of blood CO2 tensions. J Appl Physiol 1997;83:1240–6.
[17] Szegedi LL, Van der Linden P, Ducart A, Cosaert P, Poelaert J,
Vermassen F, Mortier EP, d’Hollander AA. The effects of acute
isovolemic hemodilution on oxygenation during one-lung
ventilation. Anesth Analg 2005;100:15–20.[18] McLaughlin TM, Fontana JL, Alving B, Mongan PD, Biinger.
Profound normovolemic hemodilution: hemostatic effects in
patients and in a porcine model. Anesth Analg 1996;83:
456–9.
[19] Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A. Effects of
a new modiﬁed, balanced hydroxyethyl starch preparation
(Hextend) on measures of coagulation. Br J Anaesth
2002;89(5):722–8.
[20] Cope JT, Banks D, Mauney MC, Lucktong T, Shockey KS,
Kron IL, Tribble CG. Intraoperative hetastarch infusion
impairs hemostasis after cardiac surgery operations. Ann
Thorac Surg 1997;63:78–82.
[21] Boldt J, MuE`ller M, Heesen M, Heyn O, Hempelmann G.
Inﬂuence of different volume therapies on platelet function in
the critically ill. Intensive Care Med 1996;22:1075–81.
[22] deJonge E, Levi M. Effects of different plasma substitutes on
blood coagulation: a comparative review. Crit Care Med
2001;29:1261–7.
[23] Waitzinger J, Bepperling F, Pabst G, Opitz J, MuE`ller M, Baron
JF. Pharmacokinetics and tolerability of a new
hydroxyethylstarch (HES) speciﬁcation (HES 130/0.4) after
single-dose infusion of 6% or 10% solution in healthy
volunteers. Clin Drug Invest 1998;16:151–60.
